Insurance considerations for individuals with a high risk of breast cancer in Europe: Some recommendations

P. J. Morrison; C. M. Steel; N. C. Nevin; D. G. Evans; D. M. Eccles; H. Vasen; P. Møller; S. Hodgson; D. Stoppa-Lyonnet; J. Chang-Claude; M. Caligo; E. Oláh; N. E. Haites

Insurance considerations for individuals with a high risk of breast cancer in Europe: Some recommendations

P. J. Morrison^*, C. M. Steel, N. C. Nevin, D. G. Evans, D. M. Eccles, H. Vasen, P. Møller, S. Hodgson, D. Stoppa-Lyonnet, J. Chang-Claude, M. Caligo, E. Oláh, N. E. Haites

^*Corresponding author for this work

Division of Evolution, Infection and Genomics

Research output: Contribution to journal › Review article › peer-review

Abstract

We have set out to document the current state of legislation and guidelines on insurance and genetic testing in different European countries, and to evaluate factors which will shape future developments in this complex area. The advantage of a Multi-national Demonstration Project such as this is that it can investigate the effectiveness of practice in different socio-economic contexts, their similarities and differences. These can be evaluated in the context of local services, the degree of public awareness and perception of cancer genetic issues, and the information discussed during predictive testing counselling sessions in cancer genetic clinics.

Original language	English
Pages (from-to)	272-277
Number of pages	6
Journal	CME Journal of Gynecologic Oncology
Volume	5
Issue number	3
Publication status	Published - 1 Dec 2000

Keywords

Genetic testing
Guidelines
Insurance

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{3889527a10304d048285f0529e1d6dcc,

title = "Insurance considerations for individuals with a high risk of breast cancer in Europe: Some recommendations",

abstract = "We have set out to document the current state of legislation and guidelines on insurance and genetic testing in different European countries, and to evaluate factors which will shape future developments in this complex area. The advantage of a Multi-national Demonstration Project such as this is that it can investigate the effectiveness of practice in different socio-economic contexts, their similarities and differences. These can be evaluated in the context of local services, the degree of public awareness and perception of cancer genetic issues, and the information discussed during predictive testing counselling sessions in cancer genetic clinics.",

keywords = "Genetic testing, Guidelines, Insurance",

author = "Morrison, {P. J.} and Steel, {C. M.} and Nevin, {N. C.} and Evans, {D. G.} and Eccles, {D. M.} and H. Vasen and P. M{\o}ller and S. Hodgson and D. Stoppa-Lyonnet and J. Chang-Claude and M. Caligo and E. Ol{\'a}h and Haites, {N. E.}",

year = "2000",

month = dec,

day = "1",

language = "English",

volume = "5",

pages = "272--277",

journal = "CME Journal of Gynecologic Oncology",

issn = "1219-9087",

publisher = "Primed-X Press Publishing Ltd",

number = "3",

}

TY - JOUR

T1 - Insurance considerations for individuals with a high risk of breast cancer in Europe

T2 - Some recommendations

AU - Morrison, P. J.

AU - Steel, C. M.

AU - Nevin, N. C.

AU - Evans, D. G.

AU - Eccles, D. M.

AU - Vasen, H.

AU - Møller, P.

AU - Hodgson, S.

AU - Stoppa-Lyonnet, D.

AU - Chang-Claude, J.

AU - Caligo, M.

AU - Oláh, E.

AU - Haites, N. E.

PY - 2000/12/1

Y1 - 2000/12/1

N2 - We have set out to document the current state of legislation and guidelines on insurance and genetic testing in different European countries, and to evaluate factors which will shape future developments in this complex area. The advantage of a Multi-national Demonstration Project such as this is that it can investigate the effectiveness of practice in different socio-economic contexts, their similarities and differences. These can be evaluated in the context of local services, the degree of public awareness and perception of cancer genetic issues, and the information discussed during predictive testing counselling sessions in cancer genetic clinics.

AB - We have set out to document the current state of legislation and guidelines on insurance and genetic testing in different European countries, and to evaluate factors which will shape future developments in this complex area. The advantage of a Multi-national Demonstration Project such as this is that it can investigate the effectiveness of practice in different socio-economic contexts, their similarities and differences. These can be evaluated in the context of local services, the degree of public awareness and perception of cancer genetic issues, and the information discussed during predictive testing counselling sessions in cancer genetic clinics.

KW - Genetic testing

KW - Guidelines

KW - Insurance

UR - http://www.scopus.com/inward/record.url?scp=0034520279&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0034520279

SN - 1219-9087

VL - 5

SP - 272

EP - 277

JO - CME Journal of Gynecologic Oncology

JF - CME Journal of Gynecologic Oncology

IS - 3

ER -

Insurance considerations for individuals with a high risk of breast cancer in Europe: Some recommendations

Abstract

Keywords

UN SDGs

Other files and links

Fingerprint

Cite this